key: cord-0851031-ufazj34c
authors: Baig, Abdul Mannan; Sanders, Erin C.
title: Potential Neuroinvasive Pathways of SARS‐CoV‐2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID‐19)
date: 2020-06-03
journal: J Med Virol
DOI: 10.1002/jmv.26105
sha: dec75f95aef9acb532d86be6093c59a59ef3eb41
doc_id: 851031
cord_uid: ufazj34c

COVID‐19 was declared a global pandemic on March 11, 2020. Scientists and clinicians must acknowledge that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has the potential to attack the human body in multiple ways simultaneously and exploit any weaknesses of its host. A multipronged attack could potentially explain the severity and extensive variety of signs and symptoms observed in patients with COVID‐19. Understanding the diverse tactics of this virus to infect the human body is both critical and incredibly complex. Although patients diagnosed with COVID‐19 have primarily presented with pulmonary involvement, viral invasion, and injury to diverse end organs is also prevalent and well documented in these patients, but has been largely unheeded. Human organs known for Angiotensin‐Converting Enzyme 2 (ACE2) expression including the gastrointestinal tract, kidneys, heart, adrenals, brain, and testicles are examples of extra‐pulmonary tissues with confirmed invasion by SARS‐CoV‐2. Initial multiple organ involvement may present with vague signs and symptoms to alert healthcare professionals early in the course of COVID‐19. Another example of an ongoing, yet neglected element of the syndromic features of COVID‐19, are the reported findings of loss of smell, altered taste, ataxia, headache, dizziness, and loss of consciousness, which suggest a potential for neural involvement. In this review, we further deliberate on the neuroinvasive potential of SARS‐CoV‐2, the neurologic symptomology observed in COVID‐19, the host‐virus interaction, possible routes of SARS‐CoV‐2 to invade the central nervous system (CNS), other neurologic considerations for patients with COVID‐19, and a collective call to action. This article is protected by copyright. All rights reserved.

The neuroinvasive potential of SARS-CoV-2 and possible role in the acute cardiorespiratory failure of patients with COVID-19 was first proposed by Li et al in February 2020. 24 In early March 2020, neurotropic mechanisms of SARS-CoV-2 targeting the human CNS were further described. 26 Since that time, several more studies have questioned the impact of SARS-CoV-2 on the human neurological system. 25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Further consideration is warranted that the acute cardiorespiratory failure observed in patients with COVID-19 could directly result from the neurovirulent effect of SARS-CoV-2 to induce the cessation of cardiac function and spontaneous breathing at the level of the brainstem ( Figure 3B ), which has necessitated the current demand and use of mechanical ventilators ( Figure 2F ) in the management of these patients. 26 

The New England Journal of Medicine (NEJM), recently published a case series from Italy on 5 patients with COVID-19 who presented with Guillain-Barré syndrome. 44 Of the 5 reported cases, 4 developed flaccid tetraparesis or tetraplegia, and 3 required mechanical ventilation. 44 Notably, the cerebrospinal fluid (CSF) of all 5 patients tested negative for SARS-CoV-2 by RT-PCR assay. 44 A recent publication from Spain also noted 2 patients with COVID-19 presenting with Miller Fisher syndrome, a variant of Guillain-Barré syndrome, and polyneuritis cranialis. 45 The CSF of both patients tested negative for SARS-CoV-2 by RT-PCR assay. 45 Whether the prevalence of GBS is due to direct viral attack of the myelin sheath resulting in demyelination, or a secondary effect of blood-brain barrier (BBB) permeability due to widespread inflammatory response and cytokine storm in the CNS remains to be determined. 46 Additionally, long and short term post-viral sequelae will be important to monitor. Other neuroinvasive viruses including influenza, poliovirus, and human herpesviruses have invaded and damaged the CNS in a multitude of ways over time. 17, [47] [48] [49] Capacity for viral persistence, latency, or reactivation of SARS-CoV-2 are important areas of further study.

This article is protected by copyright. All rights reserved.

Of recent concern are the increasing cases in Italy, the United States (US), and the United Kingdom (UK) of a Kawasaki-type viral inflammatory illness in children newly termed MIS-C. A 14-year-old boy in the UK and 3 children in New York passed away from complications of this disease. [50] [51] Out of the series of 8 published in the UK, the 14-yearold boy presented with a headache and suffered from a right middle cerebral artery (MCA) and anterior cerebral artery (ACA) infarction. 50 The only other child to report an initial headache in the series had a severe biventricular impairment. 50 Despite having close SARS-CoV-2 positive contacts, most children tested negative for the virus via nasal swab. 50 However, 5 presented with conjunctivitis. Viral conjunctival swab results were not reported. Shockingly, all of the children "progressed to warm, vasogenic shock, refractory to volume resuscitation and eventually requiring noradrenaline and milrinone for hemodynamic support," despite a lack of significant respiratory involvement by SARS-CoV-2. 50 In fact, 7 children required mechanical ventilation for cardiovascular stabilization. 50 These growing cases beg the question of both an ocular route of infection as well as possible disruption of cardiorespiratory stability as a pathogenic mechanism of SARS-CoV-2 ( Figure 1 ). Interestingly, the eye is also an immune-privileged site, In Michigan, a 58-year-old female with altered mental status (AMS), positive NP swab by RT-PCR assay, and suspected SARS-CoV-2 associated acute necrotizing encephalopathy (ANE) was diagnosed by head CT and magnetic resonance imaging (MRI) of the brain. Unfortunately, the CSF sample was unable to be tested for SARS-CoV-2. 54 The cause of these symptoms is still unclear, as to whether they were a result of intracranial cytokine storm compromising the blood-brain barrier (BBB) or direct viral neuroinvasion. In Florida, a 74-year-old male was diagnosed with encephalopathy and had a positive NP swab by RT-PCR assay, but again, CSF was unable to be tested for SARS-CoV-2. 55 California also reported a 41-year-old female with meningoencephalitis and positive NP swab who presented with new-onset seizures in early April. 56 After 9 days of hospitalization, the physicians were still unable to test her CSF for SARS-CoV-2.

Additionally, a 5-year-old girl from Michigan with positive NP swab and meningoencephalitis requiring intubation and ventilation succumbed to her injuries on April 19th. 57 A case report has not yet been published. As this is the second documented case of encephalitis with COVID-19 in Michigan, exploration of a more virulent strain of SARS-CoV-2 to the CNS may be justified, as China has released preliminary evidence that SARS-CoV-2 has acquired mutations capable of substantially changing its pathogenicity. 60 

A case from Italy was recently published involving a 60-year-old male with new-onset akinetic mutism and encephalopathy, positive NP swab, and negative CSF by RT-PCR assay tested twice. 58 Figure 3A) express SARS-CoV-2 entry genes and are potentially direct targets for the virus. 68 In Italy, ultrastructural analysis of a postmortem patient with COVID19 examined the olfactory nerve, the gyrus rectus, and the brainstem at the level of the medulla oblongata ( Figure 3B ). 93 Researchers found severe and widespread tissue damage and SARS-CoV-2 virion particles involving the neurons, glia, nerve axons, and myelin sheath. 93 These findings support the potential for viral invasion of the olfactory mucosa (OM) ( Figure   3A ). Additionally, a postmortem MRI study of patients with COVID-19 from Belgium revealed asymmetric olfactory bulbs ( Figure 3A ) with or without olfactory cleft obliteration in 4 out of 19 decedents. 94 Given the known cytopathic effects, replication of the virus likely potentiates cell rupture, resulting in the release of more virion into the surrounding tissues. It is well established that the OE via ON directly access the olfactory bulb (OB) through a horizontal segment of the ethmoid bone called the cribriform plate ( Figure 3A ). [95] [96] [97] [98] As the ON travel through the olfactory foramina in the cribriform plate, they also pass directly through the 3 layers of the cranial meninges (dura mater, arachnoid mater, and pia mater) before reaching the OB ( Figure 3A ). [95] [96] [97] [98] Consequently, the rupturing of infected cells through the subarachnoid space could directly release virion into the CSF ( Figure 3A , blue zone). As evidence of the presence of CSF in the meninges that support the OB above, is the phenomenon of CSF rhinorrhea resulting from a fracture of the cribriform plate in trauma involving the base of the skull. 99, 100 The CSF circulation can then transport the virus throughout the CNS with or without overt damage to the BBB or the OB ( Figure 3A ).

The intrathecal renin-angiotensin system and brain both express ACE2 and could also be potential targets for SARS-CoV-2. 101, 102 This article is protected by copyright. All rights reserved. [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] As CSF is present in the subarachnoid space of the meninges directly supporting the OB, the virus can reach the CNS without breaching the BBB. [95] [96] [97] [98] SARS-CoV-2 selecting to manipulate this direct pathway would not be unexpected, as a plethora of viruses and pathogens have been reported to invade the CNS utilizing this exact route. [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] The transcribrial route ( Figure 3A , between the olfactory mucosa and olfactory bulb) has also been proposed as a potential route for drugs to bypass the BBB and also for stem cell delivery in neurodegenerative diseases. 111, 112 Localized epithelial This article is protected by copyright. All rights reserved.

inflammation, destruction and damage to the OB ( Figure 3A, top layer) has already been observed with other viral pathogens and correlated with decreased olfaction. [113] [114] [115] This mechanism could potentially explain the diminished senses of smell and associated altered taste (Figure 2A-B) in patients with COVID-19. 92 6.2 | OTHER POTENTIAL ROUTES TO THE CNS Primary transmission via respiratory droplets supports further investigation of the mucous membranes of the eyes and mouth as other possible candidates for viral peripheral nerve invasion (Figure 1) , as both the oral and ocular epithelium express ACE2. [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] Direct invasion of the peripheral nerves in the nasal cavity leading to the trigeminal nerve has been proposed as a potential cause for headache symptoms in patients with COVID-19. 36 There is also the potential for the virus to enter the peripheral vasculature via epithelial erosion and directly invade the circulation. Once in the blood, the virus may be able to cross the BBB by causing damage to vessel integrity ( Figure 1 ) and thus increasing permeability. [116] [117] [118] [119] Recently, the ultrastructural analysis of a postmortem patient with COVID19 detected SARS-CoV-2 in the frontal lobe of the human brain ( Figure 3B ), specifically in the neurons and propagating in the capillary endothelium, (Figure 3 ) bolstering the possibility of a hematogenous route. 34 

From a neurological perspective, there are several other essential components to be considered. The significant burden of infection and associated organ and tissue damage could result in a cytokine storm (Figure 1 ), which has already been reported and could lead to clotting complications and potentially compromise the BBB. 46, 120-122

In addition to neurotropism, the presence of a virus utilizing existing ACE2 receptors in endothelia of the blood vessels of multiple organs and serum, would reduce available circulating ACE2, and increase serum levels of Angiotensin II. This phenomenon could predispose patients to microthrombi, acute clot, and stroke, which could explain the reported incidence of hypercoagulability in patients with COVID-19 ( Figure 1 ). 116-119

Autopsy examinations and histopathology of patients infected with COVID-19 are expected to provide essential information and clarity in the coming weeks. Of the reported autopsies in China, the US, and worldwide, there is very limited data on the CNS, brainstem, or peripheral nerves of the eye, nose, and mouth. [123] [124] [125] [126] [127] [128] New postmortem examinations of patients with COVID-19 in Germany revealed that of 21 brains tested, 13 were positive for SARS-CoV-2 by RT-PCR. 128 The same authors initially reported on non-specific brain findings including 2 patients with cerebral sclerosis and another with suspected septic encephalomalacia, although brain dissections are still pending. 127 

Notably, China has had markedly more time than the rest of the world to perform clinical investigations and autopsy examinations. Despite this advantage, there was an initial paucity of published autopsy and pathology reports on the CNS. Physicians and scientists from China have been vocal about their recommendations and need for more data. [135] [136] [137] Dr. Bin Cong, physician, and dean of the Hebei Medical University School of Forensic Medicine published a paper in February 2020 requesting to strengthen the use of autopsy to better comprehend SARS-CoV-2. 136 Dr. Hujun Wang, physician and chief expert in forensic medicine at Southern Medical University, also recognized the need of pathologic data on patients with COVID-19 to better understand human SARS-CoV-2 infection. 137 The majority of initial published and available reports from China involving autopsy, predominately focused on procedure safety with scarce actual autopsy and pathology reports. 126, [131] [132] [133] [134] [137] [138] [139] [140] Remarkably, only one full autopsy report was identified and able to be accessed in the full text during the early days of the COVID-19 outbreak in China. 126 Even after the spread of COVID-19 in the US and Europe, with hundreds of deaths daily, autopsy examinations were not routinely performed and crucial data on organ involvement, and the CNS in particular, remained uninvestigated. 

2D-E). Patient symptoms of anosmia, dysgeusia, headache, eye pain, conjunctivitis, and sore throat are also important to report to better understand possible transmission pathways (Figure 2A-B) . Radiological notation of the orbits, sinus, and dura may help further explain the route of infection. CSF testing for SARS-CoV-2 by RT-PCR assay should be done whenever possible and a negative test should be repeated to avoid a testing error. Notation of anticoagulation or cardiac studies would also be beneficial. In addition to imaging studies, there may also be a role for electroencephalogram (EEG) in these patients, but widespread utility and guidelines have not yet been established.

Many countries currently lack any approved testing for SARS-CoV-2 in the CSF.

Frontline healthcare professionals need appropriate RT-PCR assay for CSF, as well as national and global guidance on who to test, when to test, and when to repeat testing.

As observed with the taxonomically related SARS-CoV-1, SARS-CoV-2 has the potential to invade the CNS, as this pathogen has been isolated from the brain and CSF of patients with COVID-19. 30, 53, 93, 128 Regardless of the multiple routes (Figure 1) , the virus could take to reach the CNS, data is continuously emerging on the true extent of neurologic involvement of SARS-CoV-2. Acute respiratory failure resulting from neuronal damage to the medullary centers ( Figure 2B ) that control the spontaneous breathing process and cardiac function is conceivable and harrowing. Additionally, a more avid receptor-binding domain is postulated to allow SARS-CoV-2 to attach more securely to the human ACE2 receptor and enable it to better infect cells and spread than SARS-CoV-1. 141 The above literature and clinical observations merit urgent investigation by healthcare professionals and the scientific community into the extent of neuroinvasive potential with SARS-CoV-2, which if overlooked, could result in significantly higher morbidity and mortality for patients with COVID-19.

To fight this virus, we need transparency. We need access to all of the available autopsy and pathology data worldwide. The CNS, brainstem, and peripheral nerves of the eyes, nose, and mouth should be further examined in any existing autopsy specimens. Frontline clinicians also need appropriate testing of CSF with national and global testing guidelines.

Regardless of current specialty in surgery or medicine, the reality is that SARS-CoV-2 and COVID-19 will affect us all. The sub-specialization of medicine has siloed

*Given the immense velocity and quantity of current data, these references include date published in [brackets] and country of origin in (paratheses). For the US state is also specified

World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)

The origin, transmission, and clinical therapies on coronavirus disease

outbreak -an update on the status

The SARS-CoV-2 outbreak: what we know

Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1, complete genome. Nucleotide, National Center for Biotechnology Information (NCBI), National Library of Medicine (US)

COVID-19 Dashboard by the Center of Systems Science and Engineering (CSSE) at Johns Hopkins

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (CHINA)

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system

Infectious Myelopathies

Cerebrospinal Fluid Abnormalities in Viral Encephalitis. Sergey Tkachev, IntechOpen

Infectious myelopathies

Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication

Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells

Coronaviruses post-SARS: update on replication and pathogenesis

The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice

The cellular and molecular pathogenesis of coronaviruses

Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice

Multiple organ infection and the pathogenesis of SARS

Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome

Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis

Pathology and Pathogenesis of Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study PREPRINT (CHINA)

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients

Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms

Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19

Neurologic complications of coronavirus infections

Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity. (CHINA)

The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion

Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review

Neurologic Features in Severe SARS-CoV-2 Infection. NEJM. CORRESPONDENCE. (FRANCE)

Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)

Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)

COVID-19 is a Real Headache! Headache. 2020. (TURKEY)

Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection

Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study

Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19

AAO-HNS: Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease

COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngology-Head and Neck Surgery. PREPRINT (USA)

Loss of sense of smell as marker of COVID-19 infection. ENTUK at The Royal College of Surgeons of England

Guillain-Barre Syndrome Associated with SARS-CoV-2. NEJM. CORRESPONDENCE. (ITALY)

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 NEUROLOGY

COVID-19: consider cytokine storm syndromes and immunosuppression

University of Texas Medical Branch at Galveston

World Health Organization. Poliomyelitis

World Health Organization. Influenza (Avian and Other Zoonotic)

Hyperinflammatory shock in children during COVID-19 pandemic

Up to 147 NYC Kids Sickened by Severe New COVID Syndrome; 12 Cases Confirmed in NJ

Conjunctivitis and COVID-19: A meta-analysis Letter to the Editor

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

2020) Neurological Complications of Coronavirus Disease (COVID-19)

Behav Immun B. Meningoencephalitis without Respiratory Failure in a Young Female Patient with COVID-19 Infection in Downtown Los Angeles

5-year-old with rare complication becomes first Michigan child to die of COVID-19. The Detroit News

Steroid-responsive severe encephalopathy in SARS-CoV-2 infection PREPRINT (ITALY)

Negative Nasopharyngeal and Oropharyngeal Swab Does Not Rule Out COVID-19

Patient-derived mutations impact pathogenicity of SARS-CoV-2. PREPRINT. (CHINA)

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. PREPRINT (CHINA)

The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. PREPRINT (CHINA)

The potential genetic network of human brain SARS-CoV-2 infection PREPRINT (FRANCE)

Influenza and SARS coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. (CHINA)

Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients

SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways. Quantitative Biology. Cell Behavior. PREPRINT (UK/NETHERLANDS/FRANCE)

Single-cell RNA expression profiling shows that ACE2, the putative receptor of COVID-19, has significant expression in nasal and mouth tissues, and is co-expressed with TMPRSS2 and not co-expressed with SLC6A19 in the tissues

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Many Faces of Renin-angiotensin System -Focus on

Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro

Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system

An ocular renin-angiotensin system

Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina Braz

Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2

Identification of angiotensin converting enzyme 2 in the rodent retina

Its Receptor Subtypes in the Human Retina

Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice

Expression of the COVID-19 receptor ACE2 in the human conjunctiva. (GERMANY)

replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. The Lancet. Respiratory Medicine. (CHINA)

2019-nCoV transmission through the ocular surface must not be ignored

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study. (CHINA)

The possibility of COVID-19 transmission from eye to nose

Characteristics of Ocular Findings of Patients With Coronavirus Disease

Ocular manifestations of a hospitalized patient with confirmed 2019 novel coronavirus disease

SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection Annals of Internal Medicine. (ITALY)

CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection

First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. Minerva Anestesiologica. (ITALY)

Early postmortem brain MRI findings in COVID-19 non-survivors. PREPRINT (BELGIUM)

Gray's Anatomy: The Anatomical Basis of Clinical Practice

Novel Radiographic Assessment of the Cribriform Plate

Brain Herniation Through the Cribriform Plate: Review and Comparison to Encephaloceles in the Same Region

The forgotten foramina: a study of the anterior cribriform plate

Extracranial Repair of Pediatric Traumatic Cerebrospinal Fluid Rhinorrhea

Late Manifestations of Traumatic Lesions of the Anterior Skull Base Skull base surgery

Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis

Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease

disease/jad190721?resultNumber=0&start=0&totalResults=4166&q=Cerebrospinal+fluid+changes+in+the+renin-angiotensin+system+in+Alzheimer%27s+disease&resultsPageSize=10&rows=10E

Murine Olfactory Bulb Interneurons Survive Infection with a Neurotropic Coronavirus

Kuiken The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system

Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection

Olfactory transmission of neurotropic viruses

Localizations of the virus of poliomyelitis in the central nervous system during the preparalytic period, after intranasal instillation

Burkholderia pseudomallei Penetrates the Brain via Destruction of the Olfactory and Trigeminal Nerves: Implications for the Pathogenesis of Neurological Melioidosis

Tackling infection owing to brain-eating amoeba

Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri

Designer's microglia with novel delivery system in neurodegenerative diseases

Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain

Functional consequences following infection of the olfactory system by intranasal infusion of the olfactory bulb line variant (OBLV) of mouse hepatitis strain JHM

Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [published online ahead of print

Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis esearch. (NETHERLANDS)

Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases

CoV-2: a storm is raging

COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet

County of Santa Clara Identifies Three Additional Early COVID-19 Deaths. For Immediate release

COVID-19 Autopsies

Vander Heide RS. Pulmonary and Cardiac Pathology in Covid-19

Gross Examination Report of a COVID-19 Death Autopsy

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease

Retrospect and prospect of pathological features of coronavirus pneumonia

Pathological findings of COVID-19 associated with acute respiratory distress syndrome The Lancet Respiratory Medicine (CHINA)

Modern Pathology. (CHINA)

Silenced After Warning of Outbreak, Dies From Coronavirus

Academician Cong Bin: Autopsy of SARS-CoV-2 infection is needed to be strengthened

From SARS-CoV to SARS-CoV-2: Responses and challenges of forensic infectious disease autopsy

Recommended Guide for Forensic Pathology Examination of Deaths Related to New Coronavirus Infection

Safety protection of forensic autopsy of new coronavirus during epidemic situation

Forensic on-site inspection and corpse inspection protection during the epidemic of new coronavirus pneumonia

Structural basis of receptor recognition by SARS-CoV-2. Nature. (USA/MN)

Eating Bite Lemon Free Photo

Tuning Fork Neurology Health Free Photo

Reflex Hammer Medicine Hammer Free Photo

Emergency Medicine Artificial Respiration Medical Free Photo

The authors declare no potential conflict of interest.